Recent Blog Postings
- UPDATE: FDA Grants Fast Track Designation to Johnson & Johnson’s Investigational Therapy, Nipocalimab, for Adults with Systemic Lupus Erythematosus
- Update: Gazyva® significantly reduces disease activity in adults with systemic lupus erythematosus
- Women’s History Month: Women Leading Lupus Research